|
 |
|
|
|
|
 | Kai Lähdesmäki, MSc, Chairman of the Board.
Vice President, Business Development, BioTie Therapies since 1999.
Before that he was the CEO and co-founder of MediNet International and the President of Farmos International Division. He has almost 30 years of experience from the pharmaceutical industry. He is a Member of the Board of several companies.
Speciality: international business development and marketing. |  | Harry Jalonen, PhD, MBA, Member of the Board.
CEO of DelSiTech Ltd since 2003.
Before that he was the CEO of the mother company Bioxid Ltd and of Stick Tech Ltd. He has more than 25 years of experience from the pharmaceutical and biotechnology industries. He is the co-founder and the Member of the Board of several biotechnology companies.
Speciality: Business development, R&D and especially drug delivery. |  | Jouni Heikkilä, MD, PhD, Specialist in orthopaedics and traumatology
Ass. professor in orthopaedic and traumatology
Member of the Board.
Director of Traumatri Oy.
Dr Heikkilä has almost 20 years of experience of clinical practice and of research related to biomaterials and orthpedics. He is the Co-Founder and the Member of the Board of several companies.
Speciality: Working in clinical medicine as clinical practitioner in sportsmedicine, orthopaedic and traumatology in SportsClinic Mehiläinen and Hospital Mehiläinen, Turku. |  | Antti Yli-Urpo, DDS, PhD, Member of the Board.
Professor University of Turku, Department of Medicine.
He is a distuingished scientist with more than 30 years of experience in biomaterials research and he is one of the founders and the leader of Turku Biomaterial Research Group, a Centre of Excellence sponsored by the Finnish Academy of Science. He founded his first company Lääkintämuovi/LM Dental in 1973. He is also the Co-Founder and the Member of the Board of several other companies.
Speciality: Clinical dentistry, R&D of biomaterials and especially silica sol-gel technology. |  | Gunnar Björkstén, MBA, Vice President Business Development
Started his career in Helsinki. Moved 1972 to the Continent. Founded and run the SOFINN group of companies specialised in the introduction and marketing of Finnish high tech. Extensive experience from working with the Pharma and Biotech Industries. Executive Committee Member of Quartona. Based in London and Paris.
Speciality: Business development and finance. |  | Matti Peltola, MD, PhD, DDS, Member of the Board
Dr. Peltola has wide experience in otorhinolaryngology - head and neck surgery in biomaterials experimental and clinical research. He is a member of board in several biotechnology companies and consultant clinical advisor.
Speciality: Clinical medicine and CE marking process. |  | Martti Hintikka, MSc(Eng), Member of the Board
Managing Director, Founder and partner of Innofinance Oy.
Innofinance is a vc-company, which makes investments in seed-stage companies in different sectors. Innofinance has 5 funds under management of which 4 are investing only in seed-stage.
Speciality: Seed funding and finance. |
|
|
|
|
DelSiTech Ltd, Itäinen Pitkäkatu 4 B, 20520 Turku, Finland, Tel. +358 2 4788 640, Fax. +358 2 4788 120, Email: info delsitech.com
|
